Cannula Market By Type (Intravenous (IV) Cannulas, Arterial Cannulas, Nasal Cannulas, Surgical Cannulas, Specialized Cannulas), By Material Type (Stainless Steel, Polyurethane, Polyvinyl Chloride (PVC), Silicone, Others), By Application (Fluid and Medication Administration, Blood Sampling, Respiratory Therapy, Surgical Procedures, Cardiac Procedures, Others), By Mode (Disposable Cannulas, Reusable Cannulas), By End-User (Hospitals, Ambulatory Surgical Centers, Home Healthcare, Research & Diagnostic Laboratories, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape Cannula Market in the coming years?

The Cannula Market accounted for USD 193.40 Million in 2024 and USD 209.07 Million in 2025 is expected to reach USD 455.55 Million by 2035, growing at a CAGR of around 8.1% between 2025 and 2035. The Cannula Market is defined as the market surrounding the manufacture, supply, and sale of cannulas, which are slender tubes placed within the body to offer medical effects. The main role of cannulas is to deliver or withdraw the excess fluid, gas, or drugs, and these are vital in surgery, administration of anesthesia, and intravenous treatment. They are of different varieties, including intravenous (IV) cannulas, surgical cannulas, and nasal cannulas, among others, which are used differently for medication. Material and design advances have enhanced their safety and comfort, as well as easy-to-use procedures minimally invasive to the patients.

The growing consumer healthcare demands, popularization of minimally invasive methods, and awareness levels regarding patient care are some of the triggers for the market. The main end-users of cannulas are the hospital, clinics, and home healthcare settings. Also, the disposable and single-use cannulas are in demand because of hygiene and infection control issues. Another key area of the market is creating lightweight, flexible, and biocompatible cannulas to make them more comfortable for patients.

What do industry experts say about the Cannula market trends?

“Advancements in materials science have led to the development of cannulas that are not only more durable but also reduce patient discomfort. This progress is crucial as we aim to enhance patient outcomes and satisfaction in various medical procedures.”

• Dr. Michael Roberts, Chief Medical Officer at HealthTech Innovations

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Cannula market?

How is the rising demand for minimally invasive procedures driving the cannula market?

The rising need for minimally invasive methods largely contributes to the cannula market, especially during parenteral nutrition (PN) administration. Patients increasingly find the procedures, which are marked by less invasive incisions and shorter convalescences, beneficial to them. PN is an imperative method used in critical care, or intensive care units (ICU), to nourish patients who cannot get the necessary nutrition orally or mucosa.

One of the studies released in Clinical Nutrition Open Science has determined the use of PN in 2,984 patients of a tertiary facility, with a total day of PN experience were 68,047, representing a high degree of PN application amongst hospitalized patients. This tendency proves the necessity of the appearance of special cannulas that could be used to deliver proteins and allow secure and effective administration. With the prevalence of patient-centered care being the driving force in the healthcare industry, the consumption of protein cannulas is likely to increase due to the growing trend in the implementation of minimally invasive nutritional treatments.

In what ways does the growing prevalence of chronic diseases boost cannula usage?

The rising number of chronic diseases also contributes considerably to the cannula market, especially in the provision of parenteral nutrition (PN). The chronic health conditions, including cardiovascular diseases, diabetes, cancer, and chronic kidney disease, are common conditions that exacerbate and hinder the patients' feeding process (ability to consume sufficient nutrition through oral or intestinal route), due to which they need medical devices like protein cannulas to feed intravenously.

The Centers for Disease Control and Prevention (CDC) notes that in 2023, close to 76.4 percent of American adults reported having one or more chronic conditions, and more than 51.4 percent of them had multiple conditions. This figure demonstrates the growing need for efficient nutritional support systems and such devices as cannulas to address such conditions. With the increased attention that healthcare systems have on enhancing patient outcomes via holistic care, the popularity of protein cannulas is likely to continue growing as it is likely to respond to the need to meet the nutrient conditions of patients with chronic illnesses.

How does the high cost of advanced cannula devices limit market growth?

The exorbitant pricing of sophisticated cannula products is a significant limitation in the cannula market. They are more costly in both manufacture and acquisition than ordinary cannulas because they are usually made with special materials and a high level of engineering, and have an improved system of safety. Consequently, medical workers, especially in smaller medical establishments, outpatient services, and premises in the developing countries, are likely to be cautious of its adoption because of their financial constraints. The additional cost involved may also affect the patients in areas where there is little or no insurance coverage or reimbursement against the use of advanced medical devices.

Moreover, disposable or individual-use designs will enhance the safety at the expense of normal running expenses, which further explains the lack of excitement. Such a price obstacle might impede the purchase of technologically superior varieties of cannulas in place of the conventional varieties. Therefore, even though the advantages of increased safety, precision, and convenience, the limited market growth of advanced cannulas is expected due to the issues regarding their cost. The manufacturers are faced with the challenge of having to balance between innovation and cost-efficient solutions.

How can smart and connected cannulas improve precise fluid delivery and market growth?

The use of smart and connected cannulas is also a major opportunity for the cannula market since it allows accuracy and control in the delivery of fluids. Such innovatively incorporated devices would have sensors and digital monitoring systems to accompany the speed, amount, and composition of fluids administered and possibly prevent mistakes and enhance the safety of patients. Such accuracy especially helps clinically because in clinical settings, we see very sick patients who may need the specific dosage of medication or parenteral nutrition, which includes protein-rich solutions.

The implementation of such intelligent cannulas can increase the efficiency of the workflow of medical practitioners by reducing manual control and providing live changes. Moreover, the connected cannulas have the opportunity to relay the information to the hospital information system, facilitating improved patient management and monitoring of their outcomes. Increased attention on personalized treatment and high-tech health-related products promotes the usage of these devices. With the investment of hospitals and clinics in the technological infrastructure of digital health, smart cannulas are set to reach a speedy adoption rate.

In what ways does the growth of home healthcare and outpatient services create opportunities?

Expansion of home healthcare and outpatient services furnishes a big opportunity for the cannula market. Today, under conditions of providing medical services to more and more patients outside the usual hospital premises, there is an increased need to find reliable and easy-to-use cannulas. Patients receiving in-home healthcare, intravenous therapy, parenteral nutrition, or other fluid administration find the advantage of these cannulas as they are secure, convenient, and easy to use by a patient or caregiver.

Day surgeries and infusion facilities are also outpatient services that have a demand for portable and disposable cannulas that limit the risk of infections and drive work efficiency. The growing trend pushes the manufacturers to create non-hospital adaptable small and easy-to-use designs of cannulas that are hygienic and useful. In addition, the movement toward home and outpatient healthcare is cost-saving and makes the patients comfortable, which encourages the uptake of cannulas. Since these services are becoming more widely available in healthcare systems, the market will also expand as it requires new products that can address the needs of patients and caregivers within decentralized care environments.

What are the key market segments in the Cannula industry?

Based on the Type, the Cannula Market is classified into Intravenous (IV) Cannulas, Arterial Cannulas, Nasal Cannulas, Surgical Cannulas, and Specialized Cannulas. The most prominent segment in the cannula market is the Intravenous (IV) Cannula segment because of its use, particularly in the healthcare sector. Primarily, IV cannulas are used to give fluids, medicines, and food as a direct source of blood, making them an important aspect of patient care in hospitals and clinics and in-home treatment. They can be utilized in many different procedures, such as daily hydration therapy and complex medical procedures, hence the steady demand.

Innovation of flexible, more comfortable, and safer IV cannulas has gone a step further to encourage the use of the IV cannulas among healthcare workers. Moreover, increased usage of chronic diseases, surgical operations, and emergency care procedures adds to the increased use of IV cannulas. Disposable and single-use IV cannulas are fast gaining popularity to reduce the risk of infections and uphold hygiene levels. On the whole, clinical urgency, the enhancement of safety, and the high applicability allow the IV cannulas to remain the most popular segment on the cannula market.

Based on the Material Type, the Cannula Market is classified into Stainless Steel, Polyurethane, Polyvinyl Chloride (PVC), Silicone, and Others. The Stainless-Steel segment is the most dominant in the cannula market because of its strength, durability, and biocompatibility. The stainless-steel cannula has become a popular choice for almost all medical operations, such as intravenous care, collection of blood, and surgeries, due to its robust performance and low chance of buckling or breaking in the course of its operations. They cause less damage to the tissues because their surface is smooth, and the possibility of inserting them with ease is essential to the comfort and safety of the patient.

Moreover, stainless steel is corrosion-resistant and therefore can be used in some reusable applications where it can be sterilized multiple times. The fact that the material can be used with a variety of medical fluids and drugs also contributes to the versatility of the material in a healthcare environment. Stainless steel cannulas used by hospitals, surgical centers, and clinics are known to be strong and reliable and last long. Manufacturing innovations also resulted in increasingly thin, sharp, and precise stainless-steel cannulas that make a procedure more efficient.

Which regions are leading the Cannula market, and why?

The North American cannula market is defined by the well-developed system of healthcare and the high popularity of high-tech medical equipment. Particularly, the United States is bright with its widespread net of hospitals, outpatient facilities, and specialized surgical centers. The availability of such health amenities makes it easy to accept the various forms of cannulas, such as intravenous, nasal, and cardiac cannulas. Furthermore, the significance that the region has placed on carrying out procedures in the least invasive manner possible has stimulated the design and adoption of specific cannulas in order to facilitate medical purposes.

The market is further backed by the presence of leading medical device makers of medical devices, which guarantees the availability of new products. Additionally, the growing population of people living with chronic illnesses and the aging population means a continued demand for medical intervention where the use of cannulas is necessary. The standards by regulatory organizations are high in North America, and they assume the safety and efficacy of cannula products.

The Asia Pacific cannula market is growing exponentially, with some of the drivers of growth being an aging population, growing prevalence of chronic diseases as well as the growing healthcare infrastructure. Cannulas such as intravenous, nasal, and arterial cannulas have a high demand in countries such as China, India, Japan, South Korea, and so on. Increased surgery and the use of minimally invasive surgery also contribute to growth in the market.

There is also the rising concern of healthcare and the development of medical equipment that is improving the effectiveness and safety of cannula usage. There is the existence of established and new medical device manufacturers that are enhancing innovation and competition. Besides, the growing concern about patient comfort and infections is stimulating the emergence of specialized cannulas. On the whole, the Asia Pacific cannula market has the potential to expand even further, assisted by the convergence of demographics, healthcare progress, and market forces.  

What does the competitive landscape of the Cannula market look like?

A high level of competition exists in the global cannula market, owing to the rising demand for minimally invasive procedures and the development of medical technology. The industry is dominated by key players, which are Medtronic, Becton Dickinson (BD), Edwards Lifesciences, LivaNova, Smiths Medical, Boston Scientific Corporation, Terumo Corporation, Fisher & Paykel Healthcare Ltd, Flexicare Medical, and Medin Medical Innovations.

Innovation of products, improvement in quality, and increasing their presence globally are measures that these companies are undertaking to achieve a competitive advantage. Such strategic activities as mergers and acquisitions, partnerships, and collaborations are widely used by such firms to diversify their products and break into new markets. Rising cases of chronic diseases and the elderly population present a boost to the broader need for different forms of cannulas, such as intravenous, arterial, and nasal cannulas. There is also a trend of moving towards disposable and single-use cannulas in the market due to the fear of infection control and the health of the patient.

Cannula Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Cannula industry?

• In October 2024, Becton, Dickinson, and Company (BD) announced the commercial launch of the BD Neopak XtraFlow Glass Prefillable Syringe. This innovative product enhances the BD Neopak™ Glass Prefillable Syringe platform, which supports over 24 authorized applications, including treatments for Crohn's disease and other rare conditions.

Report Coverage:

By Type

• Intravenous (IV) Cannulas
• Arterial Cannulas
• Nasal Cannulas
• Surgical Cannulas
• Specialized Cannulas

By Material Type

• Stainless Steel
• Polyurethane
• Polyvinyl Chloride (PVC)
• Silicone
• Others

By Application

• Fluid and Medication Administration
• Blood Sampling
• Respiratory Therapy
• Surgical Procedures
• Cardiac Procedures
• Others

By Mode

• Disposable Cannulas
• Reusable Cannulas

By End-User

• Hospitals
• Ambulatory Surgical Centres
• Home Healthcare
• Research & Diagnostic Laboratories
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic
• Becton, Dickinson and Company (BD)
• Edwards Lifesciences Corporation
• LivaNova PLC
• ICU Medical, Inc.
• Terumo Corporation
• Teleflex Incorporated
• CONMED Corporation
• Boston Scientific Corporation
• Smith & Nephew
• Fisher & Paykel Healthcare
• Vapotherm Inc.
• Masimo Corporation
• Angiplast Pvt Ltd
• Denex International

Frequently Asked Questions (FAQs)